WO2004084654A1 - A process for the encapsulation of garcinia extract - Google Patents

A process for the encapsulation of garcinia extract Download PDF

Info

Publication number
WO2004084654A1
WO2004084654A1 PCT/IN2003/000086 IN0300086W WO2004084654A1 WO 2004084654 A1 WO2004084654 A1 WO 2004084654A1 IN 0300086 W IN0300086 W IN 0300086W WO 2004084654 A1 WO2004084654 A1 WO 2004084654A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
garcinia
range
powder
fruits
Prior art date
Application number
PCT/IN2003/000086
Other languages
French (fr)
Inventor
Chinnaswamy Anandha Ramakrishnan
Guddadarangavvanahally Krishnareddy Jayaprakasha
Bhabani Sankar Jena
Rajendrakumar Suresh Barhate
Samkaramthadathil Gangadhran Jayaprakashan
Karumanchi Sreesaila Mallikarjuna Raghavarao
Original Assignee
Council Of Scientific And Industrial Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Of Scientific And Industrial Research filed Critical Council Of Scientific And Industrial Research
Priority to PCT/IN2003/000086 priority Critical patent/WO2004084654A1/en
Publication of WO2004084654A1 publication Critical patent/WO2004084654A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/206—Dairy flavours
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

The present invention relates to a novel process for the encapsulation of Garcinia extract powder, which comprises (a) collecting the fruits from the species of Garcinia, (b) cutting the rinds of the fruits manually, (c) extracting with de-ionized water at a volume ratio of 1:4 for a period of 15-35 min at 110-130°C, (d) filtering the extract using filter cloth, (e) mixing of the Garcinia extract with 5-20 % (w/w) whey protein and (f) spray drying the above mixture to obtain the product in powder form.

Description

A PROCESS FOR THE ENCAPSULATION OF GARCINIA EXTRACT Field of the invention
The present invention relates to a process for the encapsulation of Garcinia extract. The present invention particularly relates to a process of obtaining Garcinia extract in powder form by encapsulation using whey protein. Background and Prior art references
As dietary supplement, (-)-Hydroxcitic acid (HCA) is an effective addition to any weight management program. Allison et al. (Crit.Rev.Food Sci.Nutr.2001, 41,1-28) has reviewed the use of HCA as one of the alternative treatments for weight loss. The derivatives of HCA have been incorporated into many pharmaceutical preparations in combination with other ingredients for the purpose of enhancing weight loss, cardioprotection, correcting the conditions of lipid abnormalities and endurance (Jena et al., 2002, J. Agric. Food Chemistry, 50,10-22). So far, HCA has been found in the fruits of certain species of Garcinia, which includes G. cambogia, G indica, G.atroviridis and G cowa (Lewis, Y.S. 1969, Methods in enzymology, 13, 613-623; Jena et al, 2002, J. Agric. Food Chemistry, 50,10-22). The chemistry and biochemistry of HCA has been discussed recently (Jena et. al., 2002, J. Agric. Food Chemistry, 50,10-22). During extensive animal studies, HCA has been proven to effectively curb appetite, suppress food intake, increase the rates of hepatic glycogen synthesis, reduce fatty acid synthesis and lipogenesis and decrease body-weight gain.
Garcinia (Family: Guttiferae) is a large genus of polygamous trees or shrubs, distributed in the tropical Asia, Africa and Polynesia. It consists of 180 species, out of which about 30 species are found in India. G. pedunculata and G. cowa are grown in Northeastern parts of India and Andaman Islands. In Assam, G. cowa is often cultivated in homesteads for its acid fruits (The Wealth of India, 1956). The fruits from both the species of Garcinia are not palatable due to their strong acid taste. In Assam, the sun-dried slices of the fruits are used for culinary purposes and as folk medicine.
Reference may be made to the commercial samples of Garcinia cambogia extracts, where the HCA is present as its calcium salt (Sawada, et al, 1997, Nihon yukagaka kaishi, vol, 1467-1474). However, the excess calcium reduces the solubility and subsequently bioavailability when it is compared to the liquid extract.
Another reference may be made to the Ashok kumar, Ravindranath, B., and Balasubramamanvam (US patent # 656314, 1996). This process involves water extraction, followed by passing through ion exchange resins and decolorisation by using activated charcoal and concentration. The main drawback of this method is the process involves too many unit operations for obtaining the final product.
Reference may be made to Majeed et al. (Majeed, M., Badmaev, V and Rajendran, R. US Patent, no 5,783,603, 1998), wherein the preparation of potassium hydroxycitrate from Garcinia fruit was reported. It involves the extraction of Garcinia fruit using alkyl alcohol, the extract was treated with potassium hydroxide and refluxed to form potassium hydroxycitrate precipitate. The main drawback of this method is the potassium salt is hygroscopic. Further, HCA is not available in natural state, limiting its bioavailability and versatile applicability for pharmaceutical purposes. It may be noted that all these references are mentioned above HCA derivative preparations. However, there is no report on the encapsulation of HCA in its native (not as derivatives) form. Objects of the invention
The main object of the present invention is to develop a novel process for the encapsulation of Garcinia extract.
Another object of the present invention is to develop a process for the encapsulation of HCA in powder form with whey protein to get stable and non- hygroscopic.
Still another object of present invention is to get encapsulated HCA powder. Summary of the Invention
Accordingly, the present invention provides a novel process for the encapsulation of Garcinia extract powder, which comprises (a) collecting the fruits from the species of Garcinia, (b) cutting the rinds of the fruits manually, (c) extracting with de-ionized water at a volume ratio of 1:4 for a period of 15-35 min at 110-130°C, (d) filtering the extract using filter cloth, (e) mixing of the Garcinia extract with 5-20 % (w/w) whey protein and (f) spray drying the above mixture to obtain the product in powder form. Detailed Description of the Invention
In accordance to the objectives of the present invention, the process of encapsulation of Garcinia extract comprising steps of: a) collecting the fruits of Garcinia pedunculata/ Garcinia cowa, b) cutting rind fruits of the plant of step (a), c) extracting the cut rind fruits of step (b) with de-ionized water for a time period of 20 to 30 minutes at a temperature range of 100-135° C, d) filtering the water extract of step (c) through a filter cloth to obtain a water extract, e) mixing the water extract of step (d) with Whey protein, and f) spray drying the mixture of step (e) to obtain the encapsulated Garcinia extract powder. In an embodiment of the invention provides a process, wherein in step (b) the size of the cut rind fruits ranges between 5 x 7 mm to 9 x 11 mm.
One more embodiment, the ratio of the plant to de-ionized water used, is in the range of 1:4 and the extraction is performed at a temperature in the range of 115°C to 125°C. Another embodiment, wherein in step (e) the weight/weight ratio of water extract of Garcinia: Whey protein is in the range of 85:15 to 90:10.
Still another embodiment, the spray drying of the water extract is performed maintaining an inlet temperature in the range of 140 to 150° C and an outlet temperature in the range of 90° to 95° C. Still another embodiment, the feed rate of water extract is in the range of 80 ml to
90 ml per minute.
Yet another embodiment, the hydroxycitric acid is obtained form the aqueous extract of Garcinia pedunculate or Garcinia Cowa.
Yet another embodiment, the hydroxycitric content of encapsulated powder of extract is in the range of 53-62% on dry basis.
Yet another embodiment, the Whey protein content of the encapsulated powder of extract is in the range of 30 - 44 % determined by Bradfort method.
One more embodiment of the invention provides a process in which the encapsulated powder of Garcinia extract contains hydroxycitric acid in the native form and it is stable and non-hygroscopic.
Another embodiment, the encapsulated powder of Garcinia extract possesses better bioavailability. It also provides essential amino acids.
In the present invention, rinds of G. pedunculata / G.cowa were cut into small pieces and extracted with de-ionized water. The above extract was filtered through filter cloth. The entire filtrate was mixed with whey protein and fed to the spray dryer with a known feed rate. Spray dryer was maintained at desired inlet and outlet temperatures. Powder was collected from the bottom of the dryer in an aluminum pack and immediately sealed. The purity of the preparation was analyzed by HPLC as described by Jayaprakasha, G.K. and Sakariah, K.K. (J. Liquid Chromatography & Related Technologies, 23, 915-923, 2000). Encapsulated hydroxycitric acid powder (O.lg) quantity was dissolved in 5ml water and made up to lOOml with water and filtered. The high performance liquid chromatographic system consisted of a Hewlett Packard HPLC model HP 1100 Series (Hewlett-Packard, CA, USA), fitted with a Waters μ-Bondapack™ (Waters Corporation, Milford, MA, USA) C18 column (250 x 4.6 mm ID). The injection system (Rheodyne) used was 20 μl sample loop. Detection was done by a HP 1100 series variable wavelength detector at wavelength of 210 nm. The elution was carried out with 8 mM sulphuric acid and flow rate was 1.0 ml/min under isocratic condition. A known volume (lOμl) of the samples was injected on to the HPLC and the concentration of HCA was obtained directly from the peak area and by application of the dilution factor. The HCA concentration of the sample was expressed as g/100 g of sample. The purity of hydroxycitric acid was 20-23% and HCA lactone was 30-39% (w/w). Protein concentration was determined by Bradford method (1976) using coomassie brilliant blue G-250 using bovine serum albumin as standard. The protein content was found to be 30-44%. Product specification
(a). Color - cream white
(b). Moisture content - 8-15 % (c). Free HCA - 20-23 %
(d). HCA lactone - 30-39 %
(e). Whey protein content - 30-44%
(f). Solubility - Highly soluble in water and methanol
(g). Storage Stability - Store under humid free condition The novelty of the present invention is
1. Encapsulation of HCA is achieved in its native form and not as derivative (salt).
2. HCA powder obtained is in shelf stable, non-hygroscopic.
3. Hydroxycitrate content was 53-62 % (w/w)
4. The Garcinia extract powder obtained from the present process is highly soluble in water.
5. The final product with whey protein has additional health benefits from the angle of essential amino acid content.
The following examples are given by way of illustration of the present invention and should not be construed to limit the scope of the present invention. Example-1
Fruit rinds of G. pedunculata in 500g quantity were cut into small pieces and extracted with 1.5 liters of de-ionized water for a period of 20 min at 120°C. The above extract was filtered through filter cloth. The filtrate (1.5 kg) was mixed with 150g whey protein and fed through the spray dryer with the feed rate of 75ml/min. The inlet and outlet temperature of spray dryer was maintained at 135°C and 95 °C. HCA Powder was collected from the bottom of the dryer in an aluminum pack and sealed immediately. The HCA content was determined by HPLC method and the hydroxycitrate content was 61% (w/w). The protein content was found to be 30%. Example-2
Fruit rinds of G. cowa in lOOOg quantity were cut into small pieces and extracted with 3 liters of de-ionized water for a period of 30 min at 130 psi using autoclaving. The extract was filtered through filter cloth. The entire filtrate (3kg) was mixed with 300 g whey protein and fed through the spray dryer with the feed rate of 80ml/min. The inlet and outlet temperature of spray dryer was maintained at 150°C and 90°C,respectively. HCA powder was collected from the bottom of the dryer in an aluminum pack and sealed immediately. The HCA content was determined by HPLC method and the hydroxycitrate content was 53% (w/w). The protein content was found to be 34%.
Example-3 Fruit rinds of G. pedunculata in lOOgm quantity were cut into small pieces and extracting with 1 liter of de-ionized water for a period of 50 min at 120°C using autoclaving. The extract was filtered through filter cloth. The entire filtrate (1-kg) was mixed with 15g of whey protein and fed through the spray dryer with the feed rate of 95 ml/min. The inlet and outlet temperature of spray dryer was maintained at 155°C and 94°C, respectively. Powder was collected from the bottom of the dryer in an aluminum pack and immediately sealed. The HCA content was determined by HPLC method and the hydroxycitrate content was 62% (w/w). The protein content was found to be 31%. The main advantages of the present invention are 1. This is a simple process for obtaining the encapsulated Garcinia powder. 2. This encapsulated of Garcinia powder is in its native form without being any of its derivatives like sodium, potassium and calcium salts. Hence, it will have better bioavailability. 3. Recovery of final product is high, because it is less hygroscopic.

Claims

Claims
1. A process for the encapsulation of Garcinia extract the said process comprising steps of: a) collecting the fruits of Garcinia pedunculata Garcinia cowa, b) cutting rind fruits of the plant of step (a), c) extracting the cut rind fruits of step (b) with de-ionized water for a time period of 20 to 30 minutes at a temperature range of 100-135° C, d) filtering the water extract of step (c) through a filter cloth to obtain a water extract, e) mixing the water extract of step (d) with Whey protein, and f) spray drying the mixture of step (e) to obtain the encapsulated Garcinia extract powder.
2. A process as claimed in claim 1, wherein in step (b) the size of the cut rind fruits ranges between 5 x 7 mm to 9 x 11 mm.
3. A process as claimed in claim 1, wherein in step (c) the ratio of the plant to de-ionized water used, is in the range of 1 :4.
4. A process as claimed in claim 1, wherein in step (c) the extraction is performed at a temperature in the range of 115° C to 125°C.
5. A process as claimed in claim 1 wherein in step (e), the weight/weight ratio of water extract of Garcinia: Whey protein is in the range of 85:15 to 90:10.
6. A process as claimed in claim 1, wherein in step (f) the spray drying of the water extract is performed maintaining an inlet temperature in the range of 140 to 150° C and an outlet temperature in the range of 90° to 95°C.
7. A process as claimed in claim 1, wherein in step (f) the feed rate of water extract is in the range of 80 ml to 90 ml per minute.
8. A process as claimed in claim 1, wherein the hydroxycitric acid is obtained form the aqueous extract of Garcinia pedunculate or Garcinia Cowa.
9. A process as claimed in claim 1, wherein the hydroxycitric content of encapsulated powder of extract is in the range of 53-62% on dry basis.
10. A process as claimed in claim 1, wherein the Whey protein content of the encapsulated powder of extract is in the range of 30 - 44 % determined by Bradfort method.
11. A process as claimed in claim 1, wherein encapsulated powder of Garcinia extract contains hydroxycitric acid in the native form.
12. A process as claimed in claim 1, wherein the encapsulated powder of Garcinia extract is a stable and non-hygroscopic.
13. A process as claimed in claim 1 wherein the encapsulated powder of Garcinia extract possess better bio-availability.
14. A process as claimed in claim 1, wherein the encapsulated powder of Garcinia extract provides essential amino acids.
PCT/IN2003/000086 2003-03-26 2003-03-26 A process for the encapsulation of garcinia extract WO2004084654A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000086 WO2004084654A1 (en) 2003-03-26 2003-03-26 A process for the encapsulation of garcinia extract

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004569896A JP4408815B2 (en) 2003-03-26 2003-03-26 Process for encapsulation of Garcinia extract
AU2003226621A AU2003226621B2 (en) 2003-03-26 2003-03-26 A process for the encapsulation of garcinia extract
PCT/IN2003/000086 WO2004084654A1 (en) 2003-03-26 2003-03-26 A process for the encapsulation of garcinia extract

Publications (1)

Publication Number Publication Date
WO2004084654A1 true WO2004084654A1 (en) 2004-10-07

Family

ID=33042613

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2003/000086 WO2004084654A1 (en) 2003-03-26 2003-03-26 A process for the encapsulation of garcinia extract

Country Status (3)

Country Link
JP (1) JP4408815B2 (en)
AU (1) AU2003226621B2 (en)
WO (1) WO2004084654A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012012844A1 (en) * 2010-07-29 2012-02-02 The University Of Sydney Vegetable and fruit juice powder

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536516A (en) * 1994-08-24 1996-07-16 Renaissance Herbs, Inc. Hydroxycitric acid concentrate and food products prepared therefrom
US5783603A (en) * 1995-05-15 1998-07-21 Sabinsa Corporation Potassium hydroxycitrate for the suppression of appetite and induction of weight loss
US5911992A (en) * 1997-06-12 1999-06-15 A. Glenn Braswell Method for controlling weight with hypericum perforatum and garcinia cambogia
US6160172A (en) * 1997-08-27 2000-12-12 Vittal Mallya Scientific Research Foundation Soluble double metal salt of group IA and IIA of (-) hydroxycitric acid, process of preparing the same and its use in beverages and other food products without effecting their flavor and properties
US6447807B1 (en) * 1999-09-14 2002-09-10 Dallas L. Clouatre Potassium (-)-hydroxycitric acid methods for pharmaceutical preparations for stable and controlled delivery

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536516A (en) * 1994-08-24 1996-07-16 Renaissance Herbs, Inc. Hydroxycitric acid concentrate and food products prepared therefrom
US5783603A (en) * 1995-05-15 1998-07-21 Sabinsa Corporation Potassium hydroxycitrate for the suppression of appetite and induction of weight loss
US5911992A (en) * 1997-06-12 1999-06-15 A. Glenn Braswell Method for controlling weight with hypericum perforatum and garcinia cambogia
US6160172A (en) * 1997-08-27 2000-12-12 Vittal Mallya Scientific Research Foundation Soluble double metal salt of group IA and IIA of (-) hydroxycitric acid, process of preparing the same and its use in beverages and other food products without effecting their flavor and properties
US6447807B1 (en) * 1999-09-14 2002-09-10 Dallas L. Clouatre Potassium (-)-hydroxycitric acid methods for pharmaceutical preparations for stable and controlled delivery

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GIBBS B F ET AL: "ENCAPSULATION IN THE FOOD INDUSTRY: A REVIEW", INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, CARFAX PUBLISHING LTD, GB, vol. 50, no. 3, 1999, pages 213 - 224, XP009013399, ISSN: 0963-7486 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012012844A1 (en) * 2010-07-29 2012-02-02 The University Of Sydney Vegetable and fruit juice powder
CN103108558A (en) * 2010-07-29 2013-05-15 悉尼大学 Vegetable and fruit juice powder

Also Published As

Publication number Publication date
AU2003226621A1 (en) 2004-10-18
JP2006521087A (en) 2006-09-21
AU2003226621B2 (en) 2007-09-06
JP4408815B2 (en) 2010-02-03

Similar Documents

Publication Publication Date Title
Ayaz et al. Sugar, non-volatile and phenolic acids composition of strawberry tree (Arbutus unedo L. var. ellipsoidea) fruits
JP5538611B2 (en) Maillard reaction inhibitor
Ghasemzadeh et al. Effects of solvent type on phenolics and flavonoids content and antioxidant activities in two varieties of young ginger (Zingiber officinale Roscoe) extracts
Zia-Ul-Haq et al. Compositional studies and antioxidant potential of Albizia lebbeck (L.) Benth. pods and seeds
Alasalvar et al. Antioxidant and antiradical activities in extracts of hazelnut kernel (Corylus avellana L.) and hazelnut green leafy cover
EP0283257B1 (en) Edible composition
Koponen et al. Contents of anthocyanins and ellagitannins in selected foods consumed in Finland
JP2009531162A (en) Extracts and methods containing green tea seeds
Kossah et al. Comparative study on the chemical composition of Syrian sumac (Rhus coriaria L.) and Chinese sumac (Rhus typhina L.) fruits
CN103524596B (en) Antioxidative peptide of shark protein as well as preparation method and use thereof
JP2009531331A (en) Extracts and methods comprising cinnamon seeds
JP2003508040A (en) Morinda citrifolia dietary fiber
Nour et al. Antioxidant capacity, phenolic compounds and minerals content of blackcurrant (Ribes nigrum L.) leaves as influenced by harvesting date and extraction method
Senica et al. Processed elderberry (Sambucus nigra L.) products: A beneficial or harmful food alternative?
CA2227777A1 (en) Process for extraction of proanthocyanidins from botanical material
CN103652157B (en) A kind of instant molecular health-care tea
EP0893449A1 (en) Antitumor substance extracted from hen-of-the-woods
CN101912480A (en) Method for preparing procyanidin extract of lycium ruthenicum murr
JP3808494B2 (en) Method for producing high content of proanthocyanidins
JPWO2006090935A1 (en) Pecer derived from acerola fruit and its use
JP2004521934A (en) Methods for obtaining lignans, pharmaceutical compositions and uses thereof
KR101747125B1 (en) Method for manufacturing substance containing nobiletin and tangeretin derived from citrus fruits, and nobiletin- and tangeretin-containing substance obtained thereby
US7879383B2 (en) Rosemary herbal beverage powder and process
AU2003296185B2 (en) Composition containing high concentration of isoflavone and having high solubility and process for producing the same
US20180077938A1 (en) Process to elaborate a biostimulant based on seaweeds

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2004569896

Country of ref document: JP

Ref document number: 1-2005-501732

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 2003226621

Country of ref document: AU

122 Ep: pct application non-entry in european phase